Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?
The branched chain amino acids (BCAAs) are leucine, valine and isoleucine. A multi-million dollar industry of nutritional supplements has grown around the concept that dietary supplements of BCAAs alone produce an anabolic response in humans driven by a stimulation of muscle protein synthesis. In th...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | Journal of the International Society of Sports Nutrition |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/s12970-017-0184-9 |
_version_ | 1797685047687380992 |
---|---|
author | Robert R. Wolfe |
author_facet | Robert R. Wolfe |
author_sort | Robert R. Wolfe |
collection | DOAJ |
description | The branched chain amino acids (BCAAs) are leucine, valine and isoleucine. A multi-million dollar industry of nutritional supplements has grown around the concept that dietary supplements of BCAAs alone produce an anabolic response in humans driven by a stimulation of muscle protein synthesis. In this brief review the theoretical and empirical bases for that claim are discussed. Theoretically, the maximal stimulation of muscle protein synthesis in the post-absorptive state in response to BCAAs alone is the difference between muscle protein breakdown and muscle protein synthesis (about 30% greater than synthesis), because the other EAAs required for synthesis of new protein can only be derived from muscle protein breakdown. Realistically, a maximal increase in muscle protein synthesis of 30% is an over-estimate because the obligatory oxidation of EAAs can never be completely suppressed. An extensive search of the literature has revealed no studies in human subjects in which the response of muscle protein synthesis to orally-ingested BCAAs alone was quantified, and only two studies in which the effect of intravenously infused BCAAs alone was assessed. Both of these intravenous infusion studies found that BCAAs decreased muscle protein synthesis as well as protein breakdown, meaning a decrease in muscle protein turnover. The catabolic state in which the rate of muscle protein breakdown exceeded the rate of muscle protein synthesis persisted during BCAA infusion. We conclude that the claim that consumption of dietary BCAAs stimulates muscle protein synthesis or produces an anabolic response in human subjects is unwarranted. |
first_indexed | 2024-03-12T00:38:43Z |
format | Article |
id | doaj.art-f0aa9caf92b246738395ec11835f53c7 |
institution | Directory Open Access Journal |
issn | 1550-2783 |
language | English |
last_indexed | 2024-03-12T00:38:43Z |
publishDate | 2017-08-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of the International Society of Sports Nutrition |
spelling | doaj.art-f0aa9caf92b246738395ec11835f53c72023-09-15T09:19:29ZengTaylor & Francis GroupJournal of the International Society of Sports Nutrition1550-27832017-08-0114110.1186/s12970-017-0184-912129997Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?Robert R. Wolfe0University of Arkansas for Medical SciencesThe branched chain amino acids (BCAAs) are leucine, valine and isoleucine. A multi-million dollar industry of nutritional supplements has grown around the concept that dietary supplements of BCAAs alone produce an anabolic response in humans driven by a stimulation of muscle protein synthesis. In this brief review the theoretical and empirical bases for that claim are discussed. Theoretically, the maximal stimulation of muscle protein synthesis in the post-absorptive state in response to BCAAs alone is the difference between muscle protein breakdown and muscle protein synthesis (about 30% greater than synthesis), because the other EAAs required for synthesis of new protein can only be derived from muscle protein breakdown. Realistically, a maximal increase in muscle protein synthesis of 30% is an over-estimate because the obligatory oxidation of EAAs can never be completely suppressed. An extensive search of the literature has revealed no studies in human subjects in which the response of muscle protein synthesis to orally-ingested BCAAs alone was quantified, and only two studies in which the effect of intravenously infused BCAAs alone was assessed. Both of these intravenous infusion studies found that BCAAs decreased muscle protein synthesis as well as protein breakdown, meaning a decrease in muscle protein turnover. The catabolic state in which the rate of muscle protein breakdown exceeded the rate of muscle protein synthesis persisted during BCAA infusion. We conclude that the claim that consumption of dietary BCAAs stimulates muscle protein synthesis or produces an anabolic response in human subjects is unwarranted.http://dx.doi.org/10.1186/s12970-017-0184-9leucinevalineisoleucinehumansanabolic response |
spellingShingle | Robert R. Wolfe Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? Journal of the International Society of Sports Nutrition leucine valine isoleucine humans anabolic response |
title | Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? |
title_full | Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? |
title_fullStr | Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? |
title_full_unstemmed | Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? |
title_short | Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? |
title_sort | branched chain amino acids and muscle protein synthesis in humans myth or reality |
topic | leucine valine isoleucine humans anabolic response |
url | http://dx.doi.org/10.1186/s12970-017-0184-9 |
work_keys_str_mv | AT robertrwolfe branchedchainaminoacidsandmuscleproteinsynthesisinhumansmythorreality |